The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Hosted on MSN57m
Non-Opioid Pain Medication Journavx Gets FDA ApprovalThe Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback